On the B2C front, Karma runs 25 clinics presently with consultations, diagnostics & pharmacy services, across four states
The startup looks to expand its clinic footprint to 80 in seven states
For the B2B partners, it offers a secured, cloud-based tech platform customised for public health partnerships
Healthtech startup Karma Primary Healthcare has bagged an undisclosed amount of Series A funding from Innospark Ventures, 1Crowd, Innovative Directions, Aanshi LLP, Social Innovation Circle, Sunil Mishra and other angel investors. The startup aims to use the funds for product development.
Founded in 2014 by Jagdeep Gambhir, the Udaipur-based healthtech startup aims to bridge the prevailing gaps in the rural healthcare sector. It aims to increase awareness, promote preventive healthcare, improve supply chain efficiencies, and improve curative service delivery.
Karma claims to have built a robust and comprehensive primary healthcare delivery solution to offer real-time online video consultations and deliver healthcare to users via its facility-based, paramedic-assisted clinics. According to Karma, this way it is developing a comprehensive ecosystem of clinical treatment, quality medicines and diagnostics.
On the B2C front, Karma runs 25 clinics presently with consultations, diagnostics & pharmacy services across Rajasthan, Haryana, Gujarat, and Madhya Pradesh.
For the B2B partners it offers a secured, cloud-based tech platform customised for public health partnerships. Karma’s B2B services are available across 300+ locations within India and the startup claims to have completed more than 1.5 Mn transactions.
Commenting on the expansion goals, the founder said, “We look to expand our clinic footprint to 80 clinics in 7 states. We also look to create linkages with secondary and tertiary players to create a seamless patient experience. We are thankful to our incoming and existing investors that have shown faith in our business model, its impact and potential.”
Further, Gambhir told Inc42 that Karma also intends to bolster its marketing and branding endeavours, with a specific emphasis on leveraging data, research and analytics.
In India, the e-pharmacies are going through several government intervention and regulations for selling medicines on their platforms. Recently, the Delhi High Court (HC) came down hard on the union government for failing to formulate rules to govern the country’s burgeoning epharmacy industry.
However, the healthtech industry continues to witness growth and bag investment. Last week, Bengaluru-based fitness startup HealthifyMe raised $30 Mn in its pre-Series D funding round led by LeapFrog Investments and Khosla Ventures.
In addition, Pharmeasy aims to raise some fresh funds for which it has reportedly appointed Avendus Capital.